Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 553

1.

Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.

Hofmann SG, Meuret AE, Smits JA, Simon NM, Pollack MH, Eisenmenger K, Shiekh M, Otto MW.

Arch Gen Psychiatry. 2006 Mar;63(3):298-304.

PMID:
16520435
2.

Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.

Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E, Hodges L, Davis M.

Arch Gen Psychiatry. 2004 Nov;61(11):1136-44.

PMID:
15520361
3.

Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.

Wilhelm S, Buhlmann U, Tolin DF, Meunier SA, Pearlson GD, Reese HE, Cannistraro P, Jenike MA, Rauch SL.

Am J Psychiatry. 2008 Mar;165(3):335-41; quiz 409. doi: 10.1176/appi.ajp.2007.07050776. Epub 2008 Feb 1.

PMID:
18245177
4.

D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.

Storch EA, Merlo LJ, Bengtson M, Murphy TK, Lewis MH, Yang MC, Jacob ML, Larson M, Hirsh A, Fernandez M, Geffken GR, Goodman WK.

Int Clin Psychopharmacol. 2007 Jul;22(4):230-7. Erratum in: Int Clin Psychopharmacol. 2007 Sep;22(5):312.

PMID:
17519647
5.

A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder.

Guastella AJ, Richardson R, Lovibond PF, Rapee RM, Gaston JE, Mitchell P, Dadds MR.

Biol Psychiatry. 2008 Mar 15;63(6):544-9. doi: 10.1016/j.biopsych.2007.11.011. Epub 2008 Jan 7.

PMID:
18179785
6.

A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder.

de Kleine RA, Hendriks GJ, Kusters WJ, Broekman TG, van Minnen A.

Biol Psychiatry. 2012 Jun 1;71(11):962-8. doi: 10.1016/j.biopsych.2012.02.033. Epub 2012 Apr 4.

PMID:
22480663
7.

Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder.

Otto MW, Tolin DF, Simon NM, Pearlson GD, Basden S, Meunier SA, Hofmann SG, Eisenmenger K, Krystal JH, Pollack MH.

Biol Psychiatry. 2010 Feb 15;67(4):365-70. doi: 10.1016/j.biopsych.2009.07.036. Epub 2009 Oct 6.

PMID:
19811776
8.

A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.

Guastella AJ, Dadds MR, Lovibond PF, Mitchell P, Richardson R.

J Psychiatr Res. 2007 Sep;41(6):466-71. Epub 2006 Jul 10.

PMID:
16828803
9.

A high-throughput clinical assay for testing drug facilitation of exposure therapy.

Rodebaugh TL, Levinson CA, Lenze EJ.

Depress Anxiety. 2013 Jul;30(7):631-7. doi: 10.1002/da.22047. Epub 2013 Jan 2.

10.

Exposure therapy, D-cycloserine, and functional magnetic resonance imaging in patients with snake phobia: a randomized pilot study.

Nave AM, Tolin DF, Stevens MC.

J Clin Psychiatry. 2012 Sep;73(9):1179-86. doi: 10.4088/JCP.11m07564.

PMID:
23059145
11.

D-cycloserine augmented exposure therapy for obsessive-compulsive disorder.

Kushner MG, Kim SW, Donahue C, Thuras P, Adson D, Kotlyar M, McCabe J, Peterson J, Foa EB.

Biol Psychiatry. 2007 Oct 15;62(8):835-8. Epub 2007 Jun 22.

PMID:
17588545
12.

A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.

Norberg MM, Krystal JH, Tolin DF.

Biol Psychiatry. 2008 Jun 15;63(12):1118-26. doi: 10.1016/j.biopsych.2008.01.012. Epub 2008 Mar 7.

PMID:
18313643
13.

D-Cycloserine and performance under different states of anxiety in healthy volunteers.

Bailey JE, Papadopoulos A, Lingford-Hughes A, Nutt DJ.

Psychopharmacology (Berl). 2007 Sep;193(4):579-85. Epub 2007 May 18.

PMID:
17510758
14.

A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder.

Guastella AJ, Howard AL, Dadds MR, Mitchell P, Carson DS.

Psychoneuroendocrinology. 2009 Jul;34(6):917-23. doi: 10.1016/j.psyneuen.2009.01.005. Epub 2009 Feb 25.

PMID:
19246160
15.

Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial.

Meyerbroeker K, Powers MB, van Stegeren A, Emmelkamp PM.

Psychother Psychosom. 2012;81(1):29-37. doi: 10.1159/000329454. Epub 2011 Nov 22.

PMID:
22116378
16.

The treatment of childhood social anxiety disorder.

Beidel DC, Ferrell C, Alfano CA, Yeganeh R.

Psychiatr Clin North Am. 2001 Dec;24(4):831-46. Review.

PMID:
11723636
17.

Effects of D-cycloserine on extinction: translation from preclinical to clinical work.

Davis M, Ressler K, Rothbaum BO, Richardson R.

Biol Psychiatry. 2006 Aug 15;60(4):369-75. Review.

PMID:
16919524
18.

A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia.

Goff DC, Tsai G, Levitt J, Amico E, Manoach D, Schoenfeld DA, Hayden DL, McCarley R, Coyle JT.

Arch Gen Psychiatry. 1999 Jan;56(1):21-7.

PMID:
9892252
19.

D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions.

Smits JA, Rosenfield D, Otto MW, Marques L, Davis ML, Meuret AE, Simon NM, Pollack MH, Hofmann SG.

J Psychiatr Res. 2013 Oct;47(10):1455-61. doi: 10.1016/j.jpsychires.2013.06.020. Epub 2013 Jul 16.

20.

Extinction retention predicts improvement in social anxiety symptoms following exposure therapy.

Berry AC, Rosenfield D, Smits JA.

Depress Anxiety. 2009;26(1):22-7. doi: 10.1002/da.20511.

PMID:
18781661
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk